Valerie DeBenedette
Valerie DeBenedette is Managing Editor of Drug Topics.
Pharmacy Community Reacts to 60 Minutes/Washington Post Investigation
Pharmacy Community Reacts to 60 Minutes/Washington Post Investigation
The investigation is causing far-reaching ripples around the country, but how does it affect pharmacists?
Pharmacy Ownership Workshops and Boot Camps at NCPA
Programs promote pharmacy ownership at the NCPA Annual Conference.
Flu Season Kicks Off: What to Expect This Year
Flu Season Kicks Off: What to Expect This Year
What you (and your patients) need to know about flu vaccines this year.
Prescription Take Back Day: This Year with TimerCaps
The twice annual event will feature a new incentive this October.
Did Nasal Flu Vaccine Withdrawal Lower Vaccination Rates?
Did Nasal Flu Vaccine Withdrawal Lower Vaccination Rates?
When FluMIst was discontinued, there were worries that flu vaccination rates would drop.
FDA Safety Communication for Ocaliva
FDA Safety Communication for Ocaliva
FDA issues new communication about risk of liver injury with Ocaliva (obeticholic acid).
FDA Okays Benzodiazepines and Medication-Assisted Opioid Addiction Treatment
FDA Okays Benzodiazepines and Medication-Assisted Opioid Addiction Treatment
A new communication says benzodiazepines can be used with buprenorphine or methadone, if carefully managed.
Pharmacists Should Have Plans in Place for Disasters
Pharmacists Should Have Plans in Place for Disasters
International pharmacy group says that pharmacists should create advance plans for major disasters.
Limits on Opioid Prescriptions Gain Popularity
Limits on Opioid Prescriptions Gain Popularity
Opioid limits are gaining popularity, but do they actually work?
FDA Recommends Separate Dosing for Kayexalate
Sodium polystyrene sulfonate interferes with many oral drugs and should be dosed separately.

Poll

View Results